Cargando…

Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases

In traditional medicine, Cannabis sativa has been prescribed for a variety of diseases. Today, the plant is largely known for its recreational purpose, but it may find a way back to what it was originally known for: a herbal remedy. Most of the plant's ingredients, such as Δ(9)-tetrahydrocannab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kienzl, Melanie, Storr, Martin, Schicho, Rudolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056045/ https://www.ncbi.nlm.nih.gov/pubmed/31899693 http://dx.doi.org/10.14309/ctg.0000000000000120

Ejemplares similares

Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
por: Hasenoehrl, Carina, et al.
Publicado: (2017)

The Immune Endocannabinoid System of the Tumor Microenvironment
por: Kienzl, Melanie, et al.
Publicado: (2020)

Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity
por: Taschler, U, et al.
Publicado: (2015)

A potential role for GPR55 in gastrointestinal functions
por: Schicho, Rudolf, et al.
Publicado: (2012)

Cellular localization and regulation of receptors and enzymes of the endocannabinoid system in intestinal and systemic inflammation
por: Grill, Magdalena, et al.
Publicado: (2018)

Quantitative Metabolomic Profiling of Serum, Plasma, and Urine by (1)H NMR Spectroscopy Discriminates between Patients with Inflammatory Bowel Disease and Healthy Individuals
por: Schicho, Rudolf, et al.
Publicado: (2012)

Cannabis, Cannabinoids, and the Endocannabinoid System—Is there Therapeutic Potential for Inflammatory Bowel Disease?
por: Ambrose, Tim, et al.
Publicado: (2019)

Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of CD8(+) T and NK cells
por: Sarsembayeva, Arailym, et al.
Publicado: (2023)

The Use of Cannabinoids in the Treatment of Inflammatory Bowel Disease (IBD): A Review of the Literature
por: Nduma, Basil N, et al.
Publicado: (2023)

The anti‐parasitic drug miltefosine suppresses activation of human eosinophils and ameliorates allergic inflammation in mice
por: Knuplez, Eva, et al.
Publicado: (2021)

Opioid Use in Patients With Inflammatory Bowel Disease
por: Lin, Xiwu, et al.
Publicado: (2020)

Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer
por: Grill, Magdalena, et al.
Publicado: (2019)

NSAIDs, Opioids, Cannabinoids and the Control of Pain by the Central Nervous System
por: Vanegas, Horacio, et al.
Publicado: (2010)

Cannabinoid Therapeutic Effects in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Vinci, Antonio, et al.
Publicado: (2022)

IL-33 reduces tumor growth in models of colorectal cancer with the help of eosinophils
por: Kienzl, Melanie, et al.
Publicado: (2020)

Cannabinoids Reduce Melanoma Cell Viability and Do Not Interfere with Commonly Used Targeted Therapy in Metastatic Melanoma In Vivo and In Vitro
por: Richtig, Georg, et al.
Publicado: (2023)

Quantitative analysis of opioids and cannabinoids in wastewater samples
por: Jacox, Alethea, et al.
Publicado: (2017)

Emerging treatments for inflammatory bowel disease
por: Hazel, Karl, et al.
Publicado: (2020)

Novel treatments for inflammatory bowel disease
por: Lee, Hyo Sun, et al.
Publicado: (2018)

Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Sobolewska-Włodarczyk, Aleksandra, et al.
Publicado: (2016)

Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain
por: Yuill, Matthew B, et al.
Publicado: (2017)

Single-Port Laparoscopic Surgery for Inflammatory Bowel Disease
por: Rijcken, Emile, et al.
Publicado: (2012)

Metalloproteinases in Inflammatory Bowel Diseases
por: Marônek, Martin, et al.
Publicado: (2021)

Biologic targeting in the treatment of inflammatory bowel diseases
por: Bosani, Matteo, et al.
Publicado: (2009)

Inflammatory bowel disease: clinical aspects and treatments
por: Fakhoury, Marc, et al.
Publicado: (2014)

New treatment options for inflammatory bowel diseases
por: Verstockt, Bram, et al.
Publicado: (2018)

Insights into the treatment of inflammatory bowel disease in pregnancy
por: Shannahan, Sarah E., et al.
Publicado: (2019)

The Bowel Microbiota and Inflammatory Bowel Diseases
por: Tannock, Gerald W.
Publicado: (2010)

The atypical cannabinoid O-1602 shows antitumorigenic effects in colon cancer cells and reduces tumor growth in a colitis-associated colon cancer model
por: Kargl, Julia, et al.
Publicado: (2012)

Irritable Bowel Syndrome Is an Independent Risk Factor for Developing Opioid Use Disorder in Patients with Inflammatory Bowel Disease
por: Fu, Yuhan, et al.
Publicado: (2023)

Opioid Use Associated With Higher Costs Among Patients With Inflammatory Bowel Disease
por: Szigethy, Eva M, et al.
Publicado: (2021)

Inflammatory Bowel Disease
por: Nasseri-Moghaddam, Siavosh
Publicado: (2012)

Vedolizumab in the treatment of inflammatory bowel disease: evolving paradigms
por: Crooks, Benjamin, et al.
Publicado: (2020)

Enteric Viruses and Inflammatory Bowel Disease
por: Tarris, Georges, et al.
Publicado: (2021)

Current and emerging drugs for the treatment of inflammatory bowel disease
por: Triantafillidis, John K, et al.
Publicado: (2011)

Current status of biosimilars in the treatment of inflammatory bowel diseases
por: Park, Dong Il
Publicado: (2016)

Classical and recent advances in the treatment of inflammatory bowel diseases
por: Sales-Campos, H., et al.
Publicado: (2014)

Changing treatment paradigms for the management of inflammatory bowel disease
por: Im, Jong Pil, et al.
Publicado: (2018)

Insights on the use of biosimilars in the treatment of inflammatory bowel disease
por: Zheng, Michael K, et al.
Publicado: (2017)

The role of diet in the prevention and treatment of Inflammatory Bowel Diseases
por: Rosa, Reddavide, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pg4scijpvurm8lt7i5g8suj7ne